登出

Recap: Vanda Pharma Q2 Earnings

综述：Vanda Pharma第二季度收益

Benzinga Real-time News · 2022/08/03 17:10

Vanda Pharma (NASDAQ:VNDA) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

万达制药纳斯达克(股票代码：VNDA)于2022年8月3日(星期三)下午04：00公布了第二季度收益业绩。

Here's what investors need to know about the announcement.

以下是投资者需要知道的关于这一声明的信息。

Vanda Pharma missed estimated earnings by 54.55%, reporting an EPS of $0.05 versus an estimate of $0.11.

万达制药的每股收益低于预期54.55%，每股收益为0.05美元，低于预期的0.11美元。

Revenue was down $3.51 million from the same period last year.

营收比去年同期下降了351万美元。

Last quarter the company missed on EPS by $0.1 which was followed by a 2.04% drop in the share price the next day.

上个季度，该公司每股收益比预期低0.1美元，第二天股价下跌2.04%。

Here's a look at Vanda Pharma's past performance:

以下是Vanda Pharma过去的表现：

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.01	0.08	0.16	0.14
EPS Actual	-0.11	0.12	0.14	0.17
Revenue Estimate	58.00M	70.04M	75.00M	69.75M
Revenue Actual	60.19M	68.02M	70.09M	67.90M

季度	Q1 2022	Q4 2021	Q3 2021	Q2 2021
每股收益预估	-0.01	0.08	0.16	0.14
实际每股收益	-0.11	0.12	0.14	0.17
收入预估	58.00M	70.04M	75.00M	69.75M
实际收入	60.19M	68.02M	70.09M	67.90M

To track all earnings releases for Vanda Pharma visit their earnings calendar here.

要跟踪Vanda Pharma的所有收益发布，请访问此处的收益日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

风险及免责提示